1 |
陈会友,原耀光,江朝富,等. 洗涤血小板的质量检验和临床疗效观察[J].热带医学杂志, 2007,7(2):163-180. doi:10.3969/j.issn.1672-3619.2007.02.020
doi: 10.3969/j.issn.1672-3619.2007.02.020
|
2 |
VAMVAKAS E C, PINEDA A L. Allergic andanaphylactic reactions[M]//POPOVSKY M A. TransfusionReactions. 2nd ed.Bethesda: AABB Press, 2001:83-127.
|
3 |
熊水萍. 洗涤红细胞在反复输注红细胞患者输血治疗中的应用效果[J]. 中国当代医药, 2021,28(11):66-68.
|
4 |
SALAMA A, TEMMESFELD B, HIPPENSTIEL S, et al. A new strategy for the prevention of IgA anaphylactic transfusionreactions[J]. Transfusion, 2004, 44(4): 509-511. doi:10.1111/j.1537-2995.2004.03316.x
doi: 10.1111/j.1537-2995.2004.03316.x
|
5 |
WINTERS J L, MOORE S B, SANDESS C, et al. Transfusion of apheresis PLTsfrom IgA-deficient donors with anti-Ig A is not associated with an increase intransfusion reactions [J]. Transfusion, 2004, 44(3): 382-385. doi:10.1111/j.1537-2995.2003.00662.x
doi: 10.1111/j.1537-2995.2003.00662.x
|
6 |
李宁,叶萍,毕晓琳. 无浆血小板制备的研究[J].临床血液杂志, 2013,26(8):515-520.
|
7 |
徐文皓,李志强.非溶血性发热性输血反应[J].中国输血杂志, 2002,15(5):368. doi:10.3969/j.issn.1004-549X.2002.05.049
doi: 10.3969/j.issn.1004-549X.2002.05.049
|
8 |
卢莉娟. 去白细胞血液成分在降低输血不良反应中的应用价值[J]. 实用医技杂志, 2022,29(11):1216-1218.
|
9 |
李晓华,李建民,鲍雪临,等. 洗涤血小板制备及相关质量功能指标的研究[J]. 中国社区医师, 2022,38(27):60-62.
|
10 |
徐文皓,赵佑山,肖超,等. 骨髓增生异常综合征成分输血及部分输血反应分析[J]. 中国输血杂志, 2023,36(8):689-693.
|
11 |
王文婷,陈要臻,刘二雄,等. 血小板体外活化后高表达P选择素(CD62P)抑制细菌增殖并诱导其凋亡样改变[J]. 细胞与分子免疫学杂志, 2022,38(9):781-788.
|
12 |
徐峰. 探讨β2M、CD62P、CD63表达水平对ITP临床诊断价值的研究[J]. 河北医科大学学报, 2022,43(11):1323-1327.
|
13 |
付涌水,钱开诚,陆志刚. 临床输血(第3版)[M]. 北京:人民卫生出版社, 2012:37-40.
|
14 |
PIDCOKE H F, ADEN J K, MORA A G, et al. Ten-year analysis of transfusion in Operation Iraqi Freedom and Operation Enduring Freedom: increased plasma and platelet use correlates with improved survival[J].Trauma Acute Care Surg, 2012,73(): S445-S452. doi:10.1097/ta.0b013e3182754796
doi: 10.1097/ta.0b013e3182754796
|
15 |
NESSEN S C, EASTRIDGE B J, CRONK D, et al. Fresh whole blood use by forward surgical teams in Afghanistan is associated with improved survival compared to component therapy without platelets[J]. Transfusion, 2013,53():S107-S113. doi:10.1111/trf.12044
doi: 10.1111/trf.12044
|
16 |
ROCK G, MOLTZAN C, ALHARBI A, et al. Automated collection of blood components: their storage and transfusion[J]. Transfus Med, 2003,13(4):219-225. doi:10.1046/j.1365-3148.2003.00444.x
doi: 10.1046/j.1365-3148.2003.00444.x
|
17 |
SOLEIMANY F A. Platelet activation in stored platelet concentrates:comparision of two methods Preparation [J]. Blood Disord Transfusion, 2011,51(2):212-214.
|
18 |
王天祥,邹高峰,王锡明,等. 富血小板血浆(PRP)常温保存理化指标变化的研究[J]. 中国保健营养, 2013,1(1):36-37.
|
19 |
周永列,张继业. 血小板活化标志物及其临床意义[J]. 国外医学临床生物化学与检验学分册, 2000,21(6):299-301.
|
20 |
PFISTERSHAMMER K, MAJDIC O, STOCKL J, et al. CD63 as an activation-linked T cell costimulatory element[J].Immunol, 2004,173(10):6000-6008. doi:10.4049/jimmunol.173.10.6000
doi: 10.4049/jimmunol.173.10.6000
|
21 |
VETLESEN A, MIRLASHARI M R, TORSHEIM I A, et al.Platelet activation and residual activation potential during storage of hyper concentrated platelet products in two differentplatelet additive solutions[J] . Transfusion, 2005, 45(8): 1349-1355. doi:10.1111/j.1537-2995.2005.00218.x
doi: 10.1111/j.1537-2995.2005.00218.x
|
22 |
RINGWALD J, ALTHOFF F, ZIMMERMANN R, et al. Washingplatelet with new additive solutions: aspects on the invitro quality after 48 hours of storage[J]. Transfusion, 2006,46(2):236-243. doi:10.1111/j.1537-2995.2006.00716.x
doi: 10.1111/j.1537-2995.2006.00716.x
|
23 |
石洁,艾俊,徐安琪,等. 微小RNA作为单采血小板储存损伤标志物不同保存期的差异表达谱[J]. 临床血液学杂志, 2023,36(2):16-19.
|
24 |
杨惠宽,吴千羽,张嘉仪,等. miRNA作为血小板储存损伤标志物研究初探[J]. 临床输血与检验, 2022,24(2):176-181. doi:10.3969/j.issn.1671-2587.2022.02.008
doi: 10.3969/j.issn.1671-2587.2022.02.008
|
25 |
李文娟,何芮,尹湧华,等. 4℃冷藏保存血小板的储存损伤与应用研究进展[J]. 中国输血杂志, 2021,34(8):926-930.
|